Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • aliceb
    Member
    • Jan 2010
    • 18

    Should I sequence un-replicated blocks in RNAseq?

    Hi all,

    I am designing a new experiment to sequence transcriptomes from wasps. I have 3 treatment "environments" and 4 replicate populations in each (kept separate throughout), for a total of 12 separate rearing cages.

    I want to compare expression among treatment "environments", but of course the replicate populations should be taken into account. They are separate pools of individuals that have evolved separately. The problem is that my experimental wasps are not very cooperative, and I simply don't have 3 individuals from some of my replicate populations. So, I am trying to decide how to go about sequencing them.

    Can I assume similar variance across populations, and so get a good estimate of expression from non-replicated populations? Is this a terrible idea because they are coming from different genetic backgrounds?

    For some of my replicate populations, I have plenty of individuals. For others, just one. So, I am wondering how useful it will be to sequence those single individuals. As an alternative, I can use my limited resources differently, and just sequence more individuals from fewer replicate populations. This will tell me less about my experiment in general, but more about that population.....

    According to this thread, I can analyze using edgeR if I just have good replication in some groups: http://seqanswers.com/forums/showthread.php?t=46068

    Does anyone have experience with this? In EdgeR or other programs?

    For comparison/context, in previous sequencing from these populations, the wasps were more cooperative and I used the following design to analyze differential expression in DESeq2 (35 libraries in total):


    sel.line <- factor(c(rep("GroupB",11),rep("GroupD",12), rep ("GroupE", 12)))

    block <- factor(c(rep("1", 3), rep("2", 3), rep("3", 3), rep("4", 2),
    rep("1", 3), rep("2", 3), rep("3", 3), rep("4", 3),
    rep("1", 3), rep("2", 3), rep("3", 3), rep("4", 3)))

    ExpDesign3 <- data.frame(
    row.names = colnames(countdata3),
    sel.line = sel.line,
    block = block)

    CDS3 <- DESeqDataSetFromMatrix(countData = countdata3, colData=ExpDesign3, design= ~ block + sel.line)
    "

    In this case, block refers to replicate cages within treatment, and sel.line is the level of "interest" in my study.

    Many thanks,
    Alice

Latest Articles

Collapse

  • mylaser
    Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by mylaser
    Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
    The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
    Whether you're exploring Kheloyaar for the first time or want to understand...
    Today, 09:27 PM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    Today, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    Yesterday, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 10:04 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:08 AM
0 responses
7 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-02-2026, 11:08 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Working...